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(–)-3-Methanesulfoxymethyl-3-acetoxoymethyl-7-chloro-5-phenyl-1,4-
benzodiazepin-2-one, (–)-2, reacts with ethanethiol in the presence
of a strong base affording racemic elimination-addition product 3-
ethylthiomethyl-7-chloro-5-phenyl-1,4-benzodiazepin-2-one (4). In-
termediary 3-methylene-7-chloro-5-phenyl-1,4-benzodiazepin-2-one
(3) is formed by pericyclic C–C bond breaking during elimination of
both acyloxy groups. The second approach to a-methyl-a-amino acids
comprises kinetic resolution of racemic 3-hydroxymethyl-3-benzyl-
7-chloro-5-phenyl-1,4-benzodiazepin-2-one (7) via acetylation by
Novozym 435 lipase; enantiomeric excess (e.e.) for alcohol (3S)-(+)-7
33.2%; e.e. for acetate (3R)-(–)-8 30.2%. Opposite direction of enantio-
selectivity during acetylation of 7 and the recently studied 9 (Ref. 3)
was established by determination of absolute conformation and rela-
tive configuration at C(3) (pseudoaxial/pseudoequatorial) by com-
bining CD and 1H NMR spectroscopy.
Key words: 1,4-Benzodiazepin-2-ones, kinetic resolution, absolute
configuration.
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INTRODUCTION
Continuing our project on the preparation, determination of chiroptical
properties, and application of 3-substituted 1,4-benzodiazepin-2-ones in che-
moenzymatic syntheses of enantiomerically pure compounds (EPC),1–3 we
started investigation of 3,3-disubstituted 1,4-benzodiazepin-2-ones as chiral
templates. In order to obtain a-methyl serine and a-methyl phenylalanine
and its congeners in optically pure form, some template 1,4-benzodiazepines
should be enzymatically transformed into chiral, enantiomerically enriched,
3,3-disubstituted derivatives, and by chemical specific chemical steps trans-
formed into a-methyl-a-amino acids and their congeners.
RESULTS AND DISCUSSION
In the first approach, we took advantage of highly enantioselective
enzymatic desymmetrization of prochiral 3,3-dihydroxymethyl-1,4-benzodiaze-
pin-2-one,2 and envisaged chemoenzymatic route from this diol via monoace-
tate (–)-1 to the title compounds, as outlined in Scheme 1.
Transformation of (–)-2 into 3-acethoxymethyl-3-methyl derivative by
substitution of mesyl group by ethylthiolate group, subsequent reduction,
and final hydrolysis under conditions already explored in preparation of op-
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Scheme 1.
tically pure L-Cbo-serine,1 should afford a-methyl-amino acids, and in par-
ticular open a novel approach to a-methyl-DOPA.4–6 Optically active mesy-
late (–)-2 was prepared and submitted to reductive elimination of mesyl
group via ethylthiomethyl intermediate.7 However, substitution of the me-
syl group in (–)-2 by ethylthiolate unexpectedly afforded rac 4. The struc-
ture of 4 was deduced from 1H NMR spectra, where characteristic AX2 pat-
tern appeared at 3.28–3.40 and 3.70 ppm, and confirmed by elemental
analysis. Formation of 4 can be explained by the mechanism outlined in
Scheme 2.
Ethylthiolate anion, obtained in the presence of NaH, reacts with (–)-2
at reflux of THF to afford 4 in 66% yield. In order to ascertain intermediary
formation of 3, compound (–)-2 was treated with an equimolar quantity of
NaH in the absence of ethylthiolate anion, and 3 was isolated in 67% yield.
Characteristic signals of C=CH2 protons were found at 4.95 and 5.20 ppm,
and for the carbons at 106.53, and 158.51 ppm.
In the first step, deprotonation of the most acidic methyl group in 2
takes place, forming carbanion that enters intramolecular nucleophilic dis-
placement of mesyl group. This step presumably comprises a high level of
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Scheme 2.
concertedness, proceeding via cyclic transition state to 3. Peculiarity of the
overall process resides in the C–C bond breaking, an energetically demand-
ing step.8 Driving force of the elimination-addition process seems to involve
ring-strain release on sp3---sp2 rehybridization of C(3), and in the extended
conjugation of the azomethine (C=N) bond to the exocyclic C=C bond in the
product.
Undesired formation of rac 4 prompted another approach to optically ac-
tive 3,3-disubstituted 1,4-benzodiazepines. To this aim, rac 7 was prepared,
from 5, Scheme 3, and kinetic resolution was completed by the immobilized
lipase Novozym 435, as already reported for its C(3)-methyl congener 9.
The e.e.% of alcohol (–)-9 and acetate (+)-10 were notably lower than for
C(3)H,CH2OH congeners.
3 Obviously, additional methyl group at C(3) in 9
diminishes the difference in steric requirements for two enantiomers. We
therefore expected that the larger benzyl group at C(3) in 7 would enhance
steric differentiation of the enantiomers and consequently the enantioselec-
tivity of enzymatic acetylation.
Enzyme catalyzed acetylation of rac 7 afforded products with enantio-
morphic properties to those obtained from 9. Acetate (–)-8 was obtained
from rac 7 with 30.2% e.e., whereas from rac 9 acetate (+)-10 was obtained
with 24.5% e.e, Table I; all e.e. were determined by HPLC using chiral col-
umns. Acetates, (–)-8 and (+)-10 exhibited opposite aD values and nearly
enantiomorphic CD curves, Figure 1; for comparison CD of alkohol (+)-7 is
included. Reversal of enantioselection with the change of methyl to benzyl
group on C(3) is not unexpected, however. This effect was observed in ki-
netic resolution catalyzed by lipases even for structurally similar racemates
that differ in some groups distant from the chiral center.9–11 In our case,
there are two possible explanations; either both acetates have the same ab-
solute configuration, i.e. no inversion of enantioselection in kinetic resolu-
tion has taken place but opposite conformers of acetates 8 and 10 prevail in
the solution, or inversion of stereoselection has taken place and enantiomor-
phic conformations belong to the enantiomers with opposite configuration at
C(3). The opposite configuration is entirely supported by the CD spectra in
Figure 1. Positive Cotton effect (CE), or positive couplet, is present at ca.
260 nm in the CD spectra of (+)-7 and (+)-10, and negative CE in the CD of
(–)-8. They unequivocally reveal the presence of M-conformer in solution for
(+)-10, and P-conformer of (–)-8.2,3
M-Conformation found for alcohol (+)-7 reveals that the more reactive
enantiomer, alcohol (3R)-(–)-7, should possess P-conformation in solution;
the acetylated product (3R)-(–)-8 retains the same conformation. Thus, en-
zymatic acetylation proceeds without change of conformation in the product.
For the more reactive (3R)-7 acetylation presumably proceeds by pathway
746 A. AVGADI] AND V. [UNJI]
CHIRAL 3,3-DISUBSTITUTED 1,4-BENZODIAZEPINES 747
TABLE I
Enantioselectivity of acylation of 3-alkyl-3-hydroxymethyl-1,4-benzodiazepines
7 and 9
Compd. Conv. / %
alcohol e.e. / %
(config.)
acetate e.e. / %
(config.)
Note
7 54.3 33.2 (3S) 30.2 (3R) This work
9 54.7 33.8 (3R) 24.5 (3S) Ref. 3
Scheme 3.
A, Scheme 4, although P---M inversion of conformation at the enzyme active
site, and acetylation of the less stable M-conformer (pathway B) cannot be
entirely excluded.
It is interesting to note that 1H NMR signals for CH2Ph protons in rac
alcohol 7 and acetate 8 are very close, at 2.90 and 2.96 ppm, confirming the
same relative configuration in both compounds. Larger benzylic group is si-
tuated in pseudoaxial (ja) position on both compounds, since hydroxy-
methyl group in the starting alcohols 7 and 9 is in psuedoequatorial (je) po-
sition, for reasons discussed previously.2,3 Strong shielding of CH2OH me-
thylene protons in 7, found at 4.05, as compared to those in 9, found at 4.6
ppm, is effected by the aromatic ring of the benzylic group.
In conclusion, we have reported a parallel study of two approaches to
a-methyl-a-alkyl amino acids. The first resulted in a peculiar elimination-
addition process, and its mechanistic explanation is offered. The second
comprised enantioselective acetylation of 7 by commercial lipase. By com-
bining CD and NMR data, it was established that 7 and 9 are present in the
same relative conformations in solution, and opposite enantioselection in ace-
tylation of 7 as compared to 9 takes place with Novozym 435. The search for
a more selective microbial lipase, and exploration of a novel addition-elimi-
nation reaction, varying the structure of the starting 3,3-disubstituted 1,4-
benzodiazepin-2-one and nucleophile, is envisaged.
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Figure 1. CD spectra of the compounds (–)-7 ( ), (–)-8 (– –), (+)-10 (–  –), in MeCN.
EXPERIMENTAL
General Information
IR spectra were run on Perkin Elmer 297 spectrometer for KBr pallets. 1H and
13C NMR spectra were obtained with Varian Gemini XL 300 spectrometer in CDCl3
solutions, d in ppm is relative to TMS as internal reference, and J in Hz. HPLC:
HPLC chromatography was performed on HP 1050 chromatograph with C18 RP (Su-
pelco, 250 4.6 mm) reverse phase column; separation was monitored by HP 1050
UV detector set up at 254 nm and connected to HP 3396A integrator. Enatiomeric
excess (e.e.) was determined for 3, 4, 5, and 6 on chiral OD-R column (Diacel Co.),
using various ratios of 0.5 M NaClO4/HClO4 (pH = 2) : MeOH. M.p.'s were determi-
ned on Electrothermal Apparatus, and are not corrected. Optical rotations were ob-
tained with Optical Activity AA-10 Automatic Polarimeter in a 1 dm cell; c in g/100
ml. CD-spectra were run on Jobin-Yvon; lmax (De) in nm.
All commercial reagents were used as received.
During usual workup, all organic extracts were dried over Na2SO4 or MgSO4 and
evaporated in vacuo on a Büchi rotary evaporator.
(–)-3-Acethoxymethyl-5-phenyl-7-chloro-3-methanesulfonylmethyl-1-
methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one (2)
To the solution of compound (–)-1 (0.20 g, 0.252 mmol), prepared as in Ref. 3 in
dichloromethane (5.0 ml), triethylamine (145 ml, 1.0 mmol) was added at 3 °C, then
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Scheme 4.
after 15 min stirring methansulfonyl chloride (80 ml, 1.0 mmol) was added dropwise.
After additional stirring for 3 h, 0.1% HCl(aq) (5.0 ml) was added, and reaction mix-
ture was extracted with dichloromethane (3 10 ml), washed with NaHCO3 (3 10
ml) and water (3 10 ml). Organic extract was worked up, and crude product was
purified on silica gel column with dichloromethane–acetone (9.5 : 0.5) as eluant. 210
mg (87.2%) of crystalline (–)-2, was obtained m.p. 74–77 °C, aD = –107.0° (c = 1.7, in
THF). CD (MeCN) lmax / nm (De): 212 (+9.14), 238, (+10.80), 266 (–21.78), 291
(–7.52), 326 (+1.71).
5-Phenyl-7-chloro-3-methylene-1-methyl-2,3-dihydro-1H-1,4-
benzodiazepin-2-one (3)
When the reaction with (–)-2 was performed as described for 4, but using equi-
molar quantities of NaH, the crude product was isolated after usual work up. After
chromatography on silica gel column with dichloromethane–acetone (9.5 : 0.5) as
eluent, pure 3 was obtained in 67% yield; colourless crystalls, m.p. 138–141 °C. IR
nmax / cm–1: 1710, 1670, 1440, 1030, 700. 1H NMR d/ppm: 3.40 (s, 3H), 4.95 (s, 1H),
5.20 (s, 1H), 7.24–7.73 (m, 8H). 13C NMR d/ppm: 35.06, 106.53, 122.59, 127.66,
128.41, 129.17, 129.69, 130.43, 131.17, 131.43, 137.27, 141.61, 148.51, 165.43,
170.37.
Anal. Calcd. for C17H13N2OCl (Mr = 296.74): C 68.81, H 9.42, N 9.44%; found: C
68.92, H 4.46, N 9.51%.
3-Ethylthiomethyl-5-phenyl-7-chloro-1-methyl-2,3-dihydro-1H-1,4-
benzodiazepin-2-one (4)
To the solution of ethanthiol (132 ml, 1.8 mmol) in dry THF (5.0 ml), 80% NaH
(63 mg, 2.1 mmol) was added under stirring at ambient temperature. After 20 min,
(–)-2 (165 mg, 0.35 mmol) in THF (3.0 ml) was aded. Upon 2 hours heating under re-
flux, the reaction mixture was cooled to ambient temperature, water (10 ml) was
added and the product was extracted with dichloromethane (3 10 ml). After usual
work up and chromatography on silica gel column with dichloromethane–acetone (9 : 1)
as eluent, pure rac 4 was obtained (100 mg, 66%); colorless crystals, m.p. 103–107
°C. IR nmax / cm–1: 1710, 1630, 1230, 1030, 700. 1H NMR d/ppm: 1.23 (t, J = 7.2 Hz,
3H), 2.59 (q, J = 7.3 Hz, 2H), 3.28–3.42 (m, 2H), 3.44 (s, 3H), 3.70 (t, J = 6.4 Hz, 1H),
7.16–7.57 (m, 8H). 13C NMR d/ppm: 14.74, 26.69, 33.38, 34.98, 64.70, 122.89, 128.35,
129.23, 129.55, 129.68, 130.18, 130.68, 131.60, 137.84, 142.02, 167.27, 169.52.
Anal. Calcd. for C19H19N2SOCl (Mr = 358.88): C 63.59, H 5.34, N 7.80%; found: C
63.74, H 5.51, N 7.69%.
5-Phenyl-7-chloro-3-benzyl-3-ethoxycarbonyl-2,3-dihydro-1H-1,4-
benzodiazepin-2-one (6)
Lithium diisopropylamide (LDA) was prepared from n-BuLi in cyclohexane (1.3
ml, 26.25 mmol, Aldrich) and diisopropylamine (3.75 ml, 26.3 mmol) in dry THF (10
ml). After 30 min stirring under argon atmosphere at ambient temperature, the so-
lution was cooled to –50 °C (acetone–dry ice), and soln. of rac 5 (3.5 g, 10.2 mmol,
CRC, Comp. Ric. Chim.) in THF (15 ml) was added with a syringe. After 20 min stir-
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ring, the reaction solution was warmed up to –20 °C, and benzylchloride (3.50 ml,
30.0 mmol) was added in 45 min with a syringe. Reaction solution was slowly
warmed up to 0 °C, and then stirred for 2 h. Then water (30 ml) was added, and af-
ter usual work up, the crude product was purified by column chromatography with
dichloromethane–acetone (8.0 : 2.0) as eluent to afford 6 (2.22 g, 50.3%), colorless
crystals; m.p. 179–182 °C IR nmax / cm–1: 1720, 1680, 1490, 1320, 700. 1H NMR
d/ppm: 0.66 (t, J = 7.2 Hz, 3H), 3.45 (q, J = 7.3 Hz, 2H), 3.74 (d, J = 13. Hz, 1H), 3.86
(d, J = 13.6 Hz, 1H), 7.06–7.60 (m, 13H), 9.01 (s, 1H). 13C NMR d/ppm: 13.20, 43.68,
61.06, 74.55, 122.74, 126.85, 127.69, 128.32, 128.95, 130.01, 130.18, 130.32, 130.86,
130.94, 131.83, 135.44, 136.06, 139.16, 167.77, 169.43, 170.09.
Anal. Calcd. for C25H21N2O3Cl (Mr = 432.89): C 69.36, H 4.89, N 6.47%; found: C
69.45, H 4.81, N 6.45%.
5-Phenyl-7-chloro-3-benzyl-3-hydroxymethyl-2,3-dihydro-1H-1,4-
benzodiazepin-2-one (7)
To the solution of rac 6 (0.50 g, 1.15 mmol) in dry THF (10.0 ml), (Et)2AlH2Na
(3.0 ml, 6.0 mmol, Aldrich) was added at 0 °C. After 3 h, 15% NaOH (3.0 ml) was
added keeping the temperature below 3 °C. Thereafter, pH was adjusted to 5.0 by
HCl(aq) (1:1), and stirring was continued for 1 h at 3–5 °C. Reaction mixture was ex-
tracted with ethylacetate (3 20 ml), and organic phase was evaporated after drying
over Na2SO4. Product 7 was isolated after chromatography on silica gel using dichlo-
romethane–ethylacetate (8 : 2) as eluent; yield 0.33 g (73.4%), m.p. 100–103 °C. IR
nmax / cm–1: 3480, 2910, 1720, 1490, 700. 1H NMR d/ppm: 2.85 (d, J = 13.6 Hz, 1H),
2.95 (d, J = 13.6 Hz, 1H), 3.99 (d, J = 11.5 Hz, 1H), 4.09 (d, J = 11.6 Hz, 1H), 4.21 (t,
J = 7.3 Hz, 1H), 7.00–7.72 (m, 13H), 9.65 (s, 1H). 13C NMR d/ppm: 29.49, 31.49,
65.29, 121.83, 126.91, 128.20, 128.35, 128.75, 129.08, 129.65, 130.17, 130.55, 130.83,
132.40, 135.07, 136.43, 140.12, 167.41, 174.35.
Anal. Calcd. for C23H19N2O2Cl (Mr = 390.85): C 70.68, H 4.90, N 7.16%; found: C
70.77, H 4.96, N 7.22%.
5-Phenyl-7-chloro-3-benzyl-3-acetoxymethyl-2,3-dihydro-1H-1,4-
benzodiazepin-2-one (8)
To the solution of 7 (200 mg, 0.50 mmol) in DMF (5.0 ml), at ambient tempera-
ture, pyridine (0.2 ml) was added first, then acetyl chloride (50 ml, 0.68 mmol) over a
10 min period. The solvent was evaporated to dryness after 1 h stirring, the oily resi-
due was dissolved in ethylacetate (10 ml), washed with 10% HCl(aq) (3 x 5 ml), then
with satd. aq. bicarbonate (3 5 ml), and water. After usual work up and chromato-
graphy on silica gel with dichloromethane–ethylacetate (8.0 : 2.0), 184 mg (83.6%) of
4 was obtained; colorless crystals, m.p. 97–100 °C. IR nmax / cm–1: 1700, 1670, 1480,
1230, 700. 1H NMR d/ppm: 2.21 (s, 3H), 2.93 (d, J = 11.06 Hz, 1H), 2.99 (d, J = 11.1
Hz, 1H), 4.50 (d, J = 11.3 Hz, 1H), 4.56 (d, J = 11.3 Hz, 1H), 7.01–7.50 (m, 13H),
10.12 (s, 1H). 13C NMR d/ppm: 21.03, 33.26, 65.55, 68.90, 121.89, 127.03, 128.29,
128.35, 128.49, 128.92, 129.77, 130.01, 130.49, 131.12, 132.27, 135.29, 136.52,
140.09, 166.81, 170.84, 172.36.
Anal. Calcd. for C25H21N2O3Cl (Mr = 432.89): 69.37, H 4.89, N 6.47%; found: C
69.35, H 4.97, N 6.51%.
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Enzymatic Enantioselective Acetylation of 7
Racemic 7 (1.1 mmol) and Novozym 435 (1.75 g) were slurried in dry ethylace-
tate (50 ml), thermostated at 10 °C in a double-wall glass reactor, and magnetically
stirred. Reaction was started by addition of vinylacetate (5.0 ml, Aldrich). Samples
(20 ml) were taken at regular intervals, filtered through teflon-filter and analyzed by
HPLC on the riverse-phase column. Reaction was stopped at 52.3% conversion after
47 h. Immobilized enzyme was collected on filter, washed with ethylacetate and de-
posited for recycling. Filtrate was evaporated to dryness and the reaction mixture
was purified on silica gel column with dichloromethane–ethylacetate (9.0 : 1.0) as
eluent. 152 mg (36.1%) of alcohol (+)-7 was obtained, e.e. 33.2%, aD = +109.2° (c =
0.83 in THF). CD (CH3CN) nmax / cm–1 (De): 225 (+31.04), 241 (–41.47), 270 (–25.20),
300 (+11.84).
Acetate (–)-8 was obtained as colorless crystals, 210 mg (45.3%), e.e. 30.2%, mp.
98–101 °C, aD = –97.2° (c = 1.00 in THF). CD (CH3CN) lmax / nm) (De): 225 (–30.94),
242 (+43.67), 271 (–25.86), 300 (–12.17).
Acknowledgement. – We thank Prof. M. Hollosi, Eotvos University Budapest for
the CD spectra. This work was supported by the Ministry of Science and Technology,
Rep. of Croatia, Project no. 980701.
REFERENCES
1. A. Avdagi} and V. [unji}, Helv. Chim. Acta 81 (1998) 85–92.
2. A. Avdagi}, A. Lesac, M. Hollosi, Zs. Majer, and V. [unji}, Helv. Chim. Acta 81
(1998) 1567–1582.
3. A. Avdagi}, A. Lesac, and V. [unji}, Tetrahedron 55 (1999) 1407–1416.
4. B. G. Donner, Tetrahedron Lett. 36 (1995) 1223–1226.
5. T. H. Lowry and K. Schueller Richardson, Mechanism and Theory in Organic
Chemistry, Harper & Row Publ., New York, 1987, pp. 159–162; 746–748.
6. G. Carrea, G. Ottolina, S. Riva, A. De Amici, and S. De Micheli, in: S. Servi (Ed.),
Microbial Reagents in Organic Synthesis, Kluwer Academic Publishers, New
York, 1992, pp. 225–238.
7. C. Orrenius, N. Ohrner, D. Rottici, A. Mattson, and T. Norin, Tetrahedron:
Asymm. 6 (1995) 1217–1220.
8. H.-J. Ha, K.-N. Yoon, S.-Y. Lee, Y.-S. Park, M.-S. Lim, and Y.-G. Yim, J. Org.
Chem. 63 (1998) 8602–8066.
9. R. Chinchilla, N. Galindo, and C. Najera, Tetrahedron: Asymm. 9 (1998) 2769–
2772.
10. F. Alonso, S. G. Davies, A. S. Elend, and J. L. Haggitt, J. Chem. Soc., Perkin
Trans. 1, 1998, 257–264.
11. S. Wenglowsky and L. S. Hegedus, J. Am. Chem. Soc. 120 (1998) 12468–12473.
752 A. AVGADI] AND V. [UNJI]
SA@ETAK
Na putu prema a-metil-a-aminokiselinama; neuobi~ajena
adicija-eliminacija u 3,3-disupstituiranom 1,4-benzodiazepin-2-onima
i inverzija enantioselektivnosti u lipazom kataliziranoj acetilaciji
Amir Avdagi} i Vitomir [unji}
(–)-3-Metansulfoksimetil-3-acetoksimetil-7-kloro-5-fenil-1,4-benzodiazepin-2-on, (–)-2,
reagira s etantiolom u prisutnosti jake baze, daju}i racemi~ni produkt eliminacije-adicije
3-etiltiometil-7-klor-5-fenil-1,4-benzodiazepin-2-on (4). Intermedijarni 3-metilen-7-klor-5-
fenil-1,4-benzodiazepin-2-on (3) nastaje pericikli~kim cijepanjem veze C–C u tijeku
eliminacije obje aciloksi-skupine. Drugi pristup a-metil-a-amino-kiselinama sastoji
se u kineti~koj rezoluciji racemi~nog 3-hidroksimetil-3-benzil-7-klor-5-fenil-1,4-
benzodiazepin-2-ona (7) acetiliranjem lipazom Novozym 435; enantiomerni vi{ak
(e.v.) za alkohol (3S)-(+)-7 iznosio je 33,2%, e.v. za acetat (3R)-(–)-8 iznosio je 30,2%.
Suprotni smjer enantioselektivnosti u acetilaciji 7 i nedavno prou~avanog 9 (Ref. 2)
utvr|en je odre|ivanjem apsolutne konformacije i relativne konfiguracije na C(3)
(pseudoaksijalna/pseudoekvatorijalna), kombiniraju}i podatke CD i NMR spektro-
skopije.
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